Cytokinetics
CYTK
CYTK
276 hedge funds and large institutions have $4.95B invested in Cytokinetics in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 111 increasing their positions, 84 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 261 → 276 (+15)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
12.49% less ownership
Funds ownership: 123.61% → 111.13% (-12%)
Holders
276
Holding in Top 10
11
Calls
$50.9M
Puts
$10.1M
Top Buyers
| 1 | +$56M | |
| 2 | +$50M | |
| 3 | +$46.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$41.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$37.2M |
Top Sellers
| 1 | -$201M | |
| 2 | -$79.8M | |
| 3 | -$30.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$24M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$23.2M |